Current NDC auxiliary source row compounder:405

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 83298-348
Product Ndc: 83298-348
Product Ndc Digits: 83298348
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Norepinephrine Bitartrate
Proprietary Name Suffix: [empty]
Nonproprietary Name: Norepinephrine Bitartrate Injection
Dosage Form Name: INJECTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Mark Cuban Cost Plus Manufacturing and Compounding LLC
Establishment Name: Mark Cuban Cost Plus Manufacturing and Compounding LLC
Establishment Fei: [empty]
Substance Name: NOREPINEPHRINE BITARTRATE
Active Ingredients Info: 8 mg/8 mL
History Active Ingredients Raw: NOREPINEPHRINE BITARTRATE
History Active Ingredients Info Raw: 8 mg/8 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 83298-348-10
Package Ndc: 83298-348-10
Package Ndc Digits: 8329834810
Package Ndc11: 83298034810
Package Description: 10 VIAL, GLASS in 1 CARTON (83298-348-10) > 8 mL in 1 VIAL, GLASS
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:405
Source Row Number: 405
Source Row Hash: 9caa66c1284544eb94bc6658fd6158ffd50a28badfc1b4d4ed70ba1797993271
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "83298-348",
    "DEASCHEDULE": "",
    "LABELERNAME": "Mark Cuban Cost Plus Manufacturing and Compounding LLC",
    "SUBSTANCENAME": "NOREPINEPHRINE BITARTRATE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "83298-348-10",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Norepinephrine Bitartrate",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Norepinephrine Bitartrate Injection",
    "PACKAGEDESCRIPTION": "10 VIAL, GLASS in 1 CARTON (83298-348-10)  > 8 mL in 1 VIAL, GLASS",
    "ACTIVEINGREDIENTSINFO": "8 mg/8 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:405
Source Row Number: 405
Status Scope: package
Lookup Ndc: 83298-348-10
Lookup Ndc Digits: 8329834810
Product Ndc: 83298-348
Product Ndc Digits: 83298348
Package Ndc: 83298-348-10
Package Ndc Digits: 8329834810
Package Ndc11: 83298034810
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 9caa66c1284544eb94bc6658fd6158ffd50a28badfc1b4d4ed70ba1797993271
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20